Best Autoimmune Hepatitis Treatment Doctors in India
Dr. Murugan N
Whatsapp Us
Dr. (Col) Avnish Seth
Dr. Sanjiv Saigal
Dr. Charles Panackel
Dr. Mallikarjun Sakpal
Dr. Narendra Singh Choudhary
Dr. Geeta Malkan Billa
What Patients with Autoimmune Hepatitis Worry About Most
Autoimmune hepatitis is a chronic condition where the immune system attacks liver cells. Patients worry about long-term steroid side effects, about whether the disease will progress to cirrhosis, and about how the diagnosis affects pregnancy plans. Many are young women already on prednisolone with raised liver enzymes that wax and wane. The honest position is that autoimmune hepatitis responds well to immunosuppressive therapy in around eighty percent of patients, with long-term outcomes that match the general population when treated early. Lifelong follow-up is needed, but daily life is largely normal.
How Autoimmune Hepatitis Is Diagnosed
Diagnosis is made by combining clinical features, blood tests, and liver biopsy. Liver function tests show raised aminotransferases (alanine aminotransferase, aspartate aminotransferase). Serology looks for anti-nuclear antibodies, anti-smooth muscle antibodies, anti-liver kidney microsomal antibodies type one, and raised immunoglobulin G. Hepatitis B, hepatitis C, and drug-induced liver injury are excluded. Liver biopsy shows interface hepatitis, plasma cell infiltrates, and varying degrees of fibrosis. The simplified International Autoimmune Hepatitis Group score grades the probability of diagnosis. Magnetic resonance cholangiopancreatography rules out primary sclerosing cholangitis in atypical cases.
Treatment Options for Autoimmune Hepatitis in India
Treatment is immunosuppression. Induction is with prednisolone alone or with budesonide in non-cirrhotic patients, often combined with azathioprine for steroid sparing. Most patients are on maintenance azathioprine with low-dose or no prednisolone after induction. Mycophenolate mofetil is used for azathioprine intolerance. Tacrolimus and ciclosporin are options in refractory disease. Bone protection with calcium, vitamin D, and bisphosphonates is offered with long-term steroids. Vaccination against hepatitis A, hepatitis B, pneumococcus, and influenza is recommended. Liver transplantation is reserved for end-stage disease, with excellent long-term outcomes. Institute of Liver and Biliary Sciences, Fortis Memorial Research Institute, Medanta, Apollo Hospitals, Asian Institute of Gastroenterology, and All India Institute of Medical Sciences run dedicated autoimmune liver disease clinics.
Recovery, Success Rates, and Follow-Up
Around eighty percent of patients achieve biochemical remission within six to twelve months of starting therapy. Long-term outcomes match the general population when remission is sustained. Treatment is usually continued for at least three years before any attempt at withdrawal, and even then around half of patients relapse and need lifelong therapy. Long-term follow-up includes liver function tests every three to six months, immunoglobulin G levels, transient elastography, and surveillance for hepatocellular carcinoma in cirrhotic patients. Bone density and skin checks are part of the long-term steroid plan.
How to Choose the Right Hepatologist for Autoimmune Hepatitis
Ask the hepatologist about experience with autoimmune liver disease, access to liver biopsy and pathology with expertise in interface hepatitis, and the use of budesonide as an alternative to prednisolone. Ask about the multidisciplinary clinic, transition planning if treatment is started in childhood, pregnancy care, and the link with a liver transplant programme. Ask about the personalised plan for steroid withdrawal and azathioprine monitoring.
International Patient Support
International patients receive a single coordinator who arranges hepatology consults, blood tests, liver biopsy, and any transplant evaluation. The Cancer Rounds team supports medical visa invitation letters, accommodation, airport transfers, and multilingual support in eleven plus languages. Patients arrive from Nigeria, Bangladesh, Kenya, Ethiopia, Iraq, Oman, and the United Arab Emirates for autoimmune liver disease care. A written long-term plan and cost estimate are shared before travel.
Frequently Asked Questions
Will I be on steroids for life?
Many patients come off prednisolone after induction and stay on azathioprine alone. A trial of complete withdrawal is considered after at least two to three years of sustained remission, although around half of patients relapse and need lifelong therapy.
Is autoimmune hepatitis curable?
Autoimmune hepatitis is not cured, but it is well controlled with immunosuppression. With sustained biochemical remission, long-term outcomes match the general population. Lifelong follow-up looks for relapse and complications.
Can I have children safely?
Yes. Most patients in remission have normal pregnancies. Azathioprine and low-dose prednisolone are usually continued through pregnancy under specialist guidance. Disease flares can happen post-partum, so close monitoring is part of the plan.
Is liver biopsy essential for diagnosis?
Liver biopsy is the gold standard and confirms interface hepatitis, plasma cell infiltrates, and fibrosis. It is usually needed at diagnosis and may be repeated to assess fibrosis or to confirm sustained histological remission before treatment withdrawal.
Does autoimmune hepatitis overlap with other liver diseases?
Overlap with primary biliary cholangitis and with primary sclerosing cholangitis is recognised. Magnetic resonance cholangiopancreatography is done if cholestatic features dominate. Overlap syndromes need combined therapy and are managed by hepatologists with specialist interest.
What is budesonide and how is it different?
Budesonide is a corticosteroid with high first-pass liver metabolism, which gives strong liver effect with fewer systemic side effects than prednisolone. It is used in non-cirrhotic autoimmune hepatitis to induce and maintain remission.
